Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
Clinical trial NCT05415917 · WITHDRAWN
Trial details
- NCT number
- NCT05415917
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2024-08-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.